Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000700949 | SCV000829728 | likely benign | Ullrich congenital muscular dystrophy 2; Bethlem myopathy 2 | 2023-11-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004026535 | SCV004928482 | uncertain significance | Inborn genetic diseases | 2024-03-07 | criteria provided, single submitter | clinical testing | The c.3670C>T (p.R1224C) alteration is located in exon 18 (coding exon 17) of the COL12A1 gene. This alteration results from a C to T substitution at nucleotide position 3670, causing the arginine (R) at amino acid position 1224 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |